Circadian molecular regulation of the xenobiotic response

外源性反应的昼夜分子调节

基本信息

  • 批准号:
    9244020
  • 负责人:
  • 金额:
    $ 41.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-04-01 至 2018-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Circadian clocks have recently become recognized as modulators of a wide array of physiological processes, including glucose homeostasis, blood pressure modulation, and drug metabolism and toxicity. Several drugs, including the anti-hypertensive statins (e.g. Lipitor) and the anti-diabetic drug metformin (e.g. Glucophage), are recommended to be taken at specific times of day. However, the molecular basis for these preferences is not well understood. The underlying hypothesis of this proposal is that the cellular transport and metabolism of therapeutic drugs can be modulated at the transcriptional level by circadian repressors altering the function of nuclear hormone receptors that respond to xenobiotic ligands. Advancing our functional understanding of these receptor and repressor interactions may highlight new therapeutic strategies for treating disease. For example, defining the diurnal regulation of the xenobiotic transcriptional network could enable the prediction of optimal treatment times for existing and novel therapeutic compounds. In addition, a deeper understanding of the diurnal regulation of nuclear hormone receptor pathways that modulate the xenobiotic transcriptional response may lead to new strategies for modulating drug absorption, metabolism and/or toxicities. Our previous studies identified the circadian clock component cryptochromes (Cry1 and Cry2) as nutrient- responsive transcriptional regulators by virtue of their susceptibility to phosphorylation by AMP-activated protein kinase (AMPK) and their ability to modulate glucocorticoid receptor dependent transcription. We have also established an important role for the liver circadian clock in glucose homeostasis, via driving diurnal expression of hepatic enzymes and transporters, including AMPK. In the course of those studies, we have generated unique tools and expertise that enables us to use biochemical, genetic, molecular and physiological approaches to uncover the roles of circadian clocks and of the circadian repressors Cry1 and Cry2 specifically in nuclear hormone receptor pathways governing the control of drug transport and metabolism, in the following specific aims: 1) Characterize the interactions of Cry1 and Cry2 with the xenobiotic receptors PXR and CAR (define the species and isoform specificity and ligand dependence of cryptochrome-xenobiotic receptor interactions; identify domains and sequences required for interaction), 2) Define the role of Cry1 and Cry2 in the regulation of PXR/CAR-mediated xenobiotic metabolism (identify specific transcriptional targets of PXR and CAR that are regulated by cryptochromes, measure changes in drug transport and metabolizing activities upon cryptochrome depletion), 3) Examine the roles of circadian clocks, PXR and CAR in the efficacy of metformin treatment.
描述(由申请人提供):最近,生物钟被认为是一系列生理过程的调节剂,包括葡萄糖稳态、血压调节、药物代谢和毒性。几种药物,包括抗高血压他汀类药物(如立普妥)和抗糖尿病药物二甲双胍(如Glucophage),建议在一天中的特定时间服用。然而,这些偏好的分子基础尚不清楚。该提议的基本假设是,治疗药物的细胞运输和代谢可以在转录水平上通过昼夜节律抑制因子调节,改变对外源配体作出反应的核激素受体的功能。推进我们对这些受体和抑制因子相互作用的功能理解可能会突出治疗疾病的新治疗策略。例如,定义外源转录网络的昼夜调节可以预测现有和新型治疗化合物的最佳治疗时间。此外,对调节外源转录反应的核激素受体途径的昼夜调节的更深入了解可能会导致调节药物吸收、代谢和/或毒性的新策略。我们之前的研究发现,生物钟成分隐色素(Cry1和Cry2)是营养反应性转录调节剂,因为它们容易被amp激活的蛋白激酶(AMPK)磷酸化,并且能够调节糖皮质激素受体依赖的转录。我们还通过驱动昼夜表达确立了肝脏生物钟在葡萄糖稳态中的重要作用

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Liver Circadian Clock Modulates Biochemical and Physiological Responses to Metformin.
  • DOI:
    10.1177/0748730417710348
  • 发表时间:
    2017-08
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Henriksson E;Huber AL;Soto EK;Kriebs A;Vaughan ME;Duglan D;Chan AB;Papp SJ;Nguyen M;Afetian ME;Lamia KA
  • 通讯作者:
    Lamia KA
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Katja A Lamia其他文献

Katja A Lamia的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Katja A Lamia', 18)}}的其他基金

The SRBR 2022 Meeting: Rhythms of Life - from Molecules to Policy
SRBR 2022 会议:生命的节奏 - 从分子到政策
  • 批准号:
    10467738
  • 财政年份:
    2022
  • 资助金额:
    $ 41.87万
  • 项目类别:
CIRCADIAN REGULATION OF HIF2alpha IN RENAL CELL CARCINOMA
HIF2α 在肾细胞癌中的昼夜节律调节
  • 批准号:
    10613272
  • 财政年份:
    2022
  • 资助金额:
    $ 41.87万
  • 项目类别:
Establishing a mechanistic basis for enhanced tumorigenesis under chronic circadian disruption
建立慢性昼夜节律紊乱下增强肿瘤发生的机制基础
  • 批准号:
    10608913
  • 财政年份:
    2022
  • 资助金额:
    $ 41.87万
  • 项目类别:
Impacting Cell Growth through altered circadian proteolysis
通过改变昼夜蛋白水解影响细胞生长
  • 批准号:
    9982673
  • 财政年份:
    2017
  • 资助金额:
    $ 41.87万
  • 项目类别:
Impacting Cell Growth through altered circadian proteolysis
通过改变昼夜蛋白水解影响细胞生长
  • 批准号:
    9380870
  • 财政年份:
    2017
  • 资助金额:
    $ 41.87万
  • 项目类别:
Impacting Cell Growth through altered circadian proteolysis
通过改变昼夜蛋白水解影响细胞生长
  • 批准号:
    10367294
  • 财政年份:
    2017
  • 资助金额:
    $ 41.87万
  • 项目类别:
Impacting Cell Growth through altered circadian proteolysis
通过改变昼夜蛋白水解影响细胞生长
  • 批准号:
    10226276
  • 财政年份:
    2017
  • 资助金额:
    $ 41.87万
  • 项目类别:
Regulation of exercise physiology by mammalian cryptochromes
哺乳动物隐花色素对运动生理学的调节
  • 批准号:
    10064627
  • 财政年份:
    2017
  • 资助金额:
    $ 41.87万
  • 项目类别:
Circadian molecular regulation of the xenobiotic response
外源性反应的昼夜分子调节
  • 批准号:
    8629737
  • 财政年份:
    2013
  • 资助金额:
    $ 41.87万
  • 项目类别:
Circadian molecular regulation of the xenobiotic response
外源性反应的昼夜分子调节
  • 批准号:
    9016537
  • 财政年份:
    2013
  • 资助金额:
    $ 41.87万
  • 项目类别:

相似海外基金

Pharmacological targeting of AMP-activated protein kinase for immune cell regulation in Type 1 Diabetes
AMP 激活蛋白激酶对 1 型糖尿病免疫细胞调节的药理学靶向
  • 批准号:
    2867610
  • 财政年份:
    2023
  • 资助金额:
    $ 41.87万
  • 项目类别:
    Studentship
Establishing AMP-activated protein kinase as a regulator of adipose stem cell plasticity and function in health and disease
建立 AMP 激活蛋白激酶作为脂肪干细胞可塑性和健康和疾病功能的调节剂
  • 批准号:
    BB/W009633/1
  • 财政年份:
    2022
  • 资助金额:
    $ 41.87万
  • 项目类别:
    Fellowship
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2021
  • 资助金额:
    $ 41.87万
  • 项目类别:
    Postdoctoral Fellowships
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
AMP 激活的蛋白激酶对整合素膜运输的代谢控制控制着细胞迁移。
  • 批准号:
    459043
  • 财政年份:
    2021
  • 资助金额:
    $ 41.87万
  • 项目类别:
    Studentship Programs
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2020
  • 资助金额:
    $ 41.87万
  • 项目类别:
    Postdoctoral Fellowships
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
  • 批准号:
    10561642
  • 财政年份:
    2019
  • 资助金额:
    $ 41.87万
  • 项目类别:
Determining the role of AMP-activated protein kinase in the integration of skeletal muscle metabolism and circadian biology
确定 AMP 激活蛋白激酶在骨骼肌代谢和昼夜节律生物学整合中的作用
  • 批准号:
    532989-2019
  • 财政年份:
    2019
  • 资助金额:
    $ 41.87万
  • 项目类别:
    Postdoctoral Fellowships
Treating Diabetic Inflammation using AMP-Activated Protein Kinase Activators
使用 AMP 激活的蛋白激酶激活剂治疗糖尿病炎症
  • 批准号:
    2243045
  • 财政年份:
    2019
  • 资助金额:
    $ 41.87万
  • 项目类别:
    Studentship
The Role of AMP-activated Protein Kinase in GVHD-causing T Cells
AMP 激活的蛋白激酶在引起 GVHD 的 T 细胞中的作用
  • 批准号:
    10359032
  • 财政年份:
    2019
  • 资助金额:
    $ 41.87万
  • 项目类别:
Investigating the therapeutic potential of AMP-activated protein kinase in myotonic dystrophy type 1
研究 AMP 激活蛋白激酶在 1 型强直性肌营养不良中的治疗潜力
  • 批准号:
    428988
  • 财政年份:
    2019
  • 资助金额:
    $ 41.87万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了